Page last updated: 2024-08-17

trifluridine and Carcinoma

trifluridine has been researched along with Carcinoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Alberts, SR; Borad, MJ; Chakrabarti, S; Fernandez-Zapico, ME; Foster, N; Fruth, B; Hartgers, M; Hogenson, TL; Jin, Z; Mahipal, A; McWilliams, RR; Nguyen, T; Pitot, H; Qian, S; Tella, SH; Washburn, L; Wee Ma, W; Wessling, J1
Ahn, DH; Alberts, SR; Bekaii-Saab, TS; Borad, MJ; Chakrabarti, S; Durgin, LM; Fruth, B; Hartgers, ML; Liu, MC; Mahipal, A; McWilliams, RR; Ou, FS; Walkes, RL; Wessling, J; Zemla, TJ1
ANDERSON, SW; HEIDELBERGER, C1

Trials

2 trial(s) available for trifluridine and Carcinoma

ArticleYear
Phase II Trial of Trifluridine/Tipiracil Plus Irinotecan in Patients with Advanced, Refractory Biliary Tract Carcinoma.
    The oncologist, 2023, 10-03, Volume: 28, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biliary Tract; Carcinoma; Gastrointestinal Neoplasms; Humans; Irinotecan; Trifluridine

2023
Phase II Trial of Trifluridine/Tipiracil in Patients with Advanced, Refractory Biliary Tract Carcinoma.
    The oncologist, 2020, Volume: 25, Issue:5

    Topics: Biliary Tract; Carcinoma; Humans; Pyrrolidines; Thymine; Trifluridine; Uracil

2020

Other Studies

1 other study(ies) available for trifluridine and Carcinoma

ArticleYear
FLUORINATED PYRIMIDINES. XXI. THE TUMOR-INHIBITORY ACTIVITY OF 5-TRIFLUOROMETHYL-2'-DEOXYURIDINE.
    Cancer research, 1964, Volume: 24

    Topics: Animals; Bone Marrow; Carcinoma; Carcinoma, Ehrlich Tumor; Gastrointestinal Tract; Leukemia L1210; Leukopenia; Ligases; Mice; Neoplasms; Pharmacology; Pyrimidines; Rats; Research; Sarcoma 180; Toxicology; Trifluridine; Uracil Nucleotides

1964